a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases
Industry Biotechnology
A.I.dvisor tells us that IVA and OCGN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVA and OCGN's prices will move in lockstep.
Ticker / NAME | Correlation To IVA | 1D Price Change % | ||
---|---|---|---|---|
IVA | 100% | -2.18% | ||
OCGN - IVA | 24% Poorly correlated | +1.72% | ||
THAR - IVA | 24% Poorly correlated | -2.46% | ||
IMMP - IVA | 23% Poorly correlated | +1.38% | ||
MRNA - IVA | 23% Poorly correlated | +1.31% | ||
KRBP - IVA | 23% Poorly correlated | +2.56% | ||
More |